{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:04:15Z","timestamp":1740171855310,"version":"3.37.3"},"reference-count":37,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The maximum body mass index (BMI) before onset of type 2 diabetes (MBBO) might be used to estimate a patient\u2019s insulin secretion capacity. There have been few factors that can predict future diabetic complications at the time of diagnosis of diabetes mellitus. This study aimed to clarify the clinical usefulness of MBBO for predicting the development of advanced diabetic microvascular complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Research design and methods<\/jats:title><jats:p>This was a cross-sectional observational study. Of 1304 consecutively admitted patients with type 2 diabetes, we enrolled 435 patients for whom we could confirm their MBBO. Univariate and multivariate logistic regression analyses were performed to examine whether MBBO or BMI on admission was associated with advanced diabetic retinopathy or nephropathy. To evaluate the predictive performance of these indexes, we performed cross-validation in various models with MBBO or BMI and evaluated the areas under the curve (AUCs) yielded by these analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Univariate analyses suggested that MBBO was associated with advanced retinopathy and nephropathy, while BMI on admission was associated only with advanced nephropathy. In multivariate analyses, MBBO was significantly associated with advanced complications, while BMI on admission was not. For advanced diabetic retinopathy, the AUCs were 0.70\u20130.72, and for advanced nephropathy, the AUCs were 0.81\u20130.83. When comparing the AUCs among models, the models with MBBO sustained high predictive performance for diabetic complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MBBO was independently associated with advanced diabetic complications, while BMI on admission was not. Diabetic microvascular complications in patients with high MBBO could progress more rapidly. At the time of the diagnosis of diabetes mellitus, MBBO would enable us to predict the progress of diabetic complications.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjdrc-2021-002466","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T16:40:23Z","timestamp":1640364023000},"page":"e002466","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Maximum body mass index before onset of type 2 diabetes is independently associated with advanced diabetic complications"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-6745","authenticated-orcid":false,"given":"Harutoshi","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2468-7559","authenticated-orcid":false,"given":"Kenji","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Komukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megu","family":"Y Baden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8847-5654","authenticated-orcid":false,"given":"Yukari","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takekazu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Iwahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9665-8947","authenticated-orcid":false,"given":"Junji","family":"Kozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"2021122408400974000_9.2.e002466.1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108086","article-title":"Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"162","author":"Saeedi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"2021122408400974000_9.2.e002466.2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13340-018-0345-3","article-title":"Japanese clinical practice guideline for diabetes 2016","volume":"27","author":"Haneda","year":"2018","journal-title":"Diabetol Int"},{"key":"2021122408400974000_9.2.e002466.3","doi-asserted-by":"publisher","DOI":"10.2337\/dci20-0022"},{"key":"2021122408400974000_9.2.e002466.4","first-page":"1","article-title":"Annual dialysis data report 2016, JSDT renal data registry","volume":"4","author":"Masakane","year":"2018","journal-title":"Renal Replacement Therapy"},{"key":"2021122408400974000_9.2.e002466.5","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.diabres.2003.09.020","article-title":"History of obesity as a risk factor for both carotid atherosclerosis and microangiopathy","volume":"66","author":"Ogawa","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"2021122408400974000_9.2.e002466.6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jdiacomp.2016.02.020","article-title":"Maximum BMI and microvascular complications in a cohort of Japanese patients with type 2 diabetes: the Japan diabetes complications study","volume":"30","author":"Tanaka","year":"2016","journal-title":"J Diabetes Complications"},{"key":"2021122408400974000_9.2.e002466.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/590569","article-title":"Past obesity as well as present body weight status is a risk factor for diabetic nephropathy","volume":"2013","author":"Meguro","year":"2013","journal-title":"Int J Endocrinol"},{"key":"2021122408400974000_9.2.e002466.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"2021122408400974000_9.2.e002466.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67528-9"},{"key":"2021122408400974000_9.2.e002466.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"2021122408400974000_9.2.e002466.11"},{"key":"2021122408400974000_9.2.e002466.12","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/CIRCULATIONAHA.118.036418","article-title":"Effects of liraglutide versus placebo on cardiovascular events in patients with type 2 diabetes mellitus and chronic kidney disease","volume":"138","author":"Mann","year":"2018","journal-title":"Circulation"},{"key":"2021122408400974000_9.2.e002466.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31149-3"},{"key":"2021122408400974000_9.2.e002466.14","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvz023","article-title":"Clinical significance of the maximum body mass index before onset of type 2 diabetes for predicting beta-cell function","volume":"4","author":"Ozawa","year":"2020","journal-title":"J Endocr Soc"},{"key":"2021122408400974000_9.2.e002466.15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206266200"},{"key":"2021122408400974000_9.2.e002466.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0480-4"},{"key":"2021122408400974000_9.2.e002466.17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.33963\/KP.14945","article-title":"The prevalence of polyvascular disease in patients with carotid artery disease and peripheral artery disease","volume":"77","author":"Vlajinac","year":"2019","journal-title":"Kardiol Pol"},{"key":"2021122408400974000_9.2.e002466.18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/clc.23266","article-title":"The association between hyperuricemia and coronary artery calcification development: a systematic review and meta-analysis","volume":"42","author":"Liang","year":"2019","journal-title":"Clin Cardiol"},{"key":"2021122408400974000_9.2.e002466.19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1507\/endocrj.EJ14-0456","article-title":"Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area","volume":"62","author":"Fujita","year":"2015","journal-title":"Endocr J"},{"key":"2021122408400974000_9.2.e002466.20","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-S002"},{"key":"2021122408400974000_9.2.e002466.21","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.diabres.2007.01.053","article-title":"Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy","volume":"77","author":"Yasuda","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"2021122408400974000_9.2.e002466.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04684-3"},{"key":"2021122408400974000_9.2.e002466.23","first-page":"387","article-title":"Obstructive sleep apnea: a prediction model using supervised machine learning method","volume":"272","author":"Keshavarz","year":"2020","journal-title":"Stud Health Technol Inform"},{"key":"2021122408400974000_9.2.e002466.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2199-0"},{"key":"2021122408400974000_9.2.e002466.25","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0942"},{"key":"2021122408400974000_9.2.e002466.26","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.128"},{"key":"2021122408400974000_9.2.e002466.27","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr561"},{"key":"2021122408400974000_9.2.e002466.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4435-8"},{"key":"2021122408400974000_9.2.e002466.29","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.4103\/1319-2442.275474","article-title":"Noninvasive method of differentiating diabetic nephropathy and nondiabetic renal disease using serum bone morphogenetic protein-7 and transforming growth factor-beta 1 levels in patients with type-2 diabetes mellitus","volume":"30","author":"John","year":"2019","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2021122408400974000_9.2.e002466.30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15046184"},{"key":"2021122408400974000_9.2.e002466.31","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700095"},{"key":"2021122408400974000_9.2.e002466.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-018-0280-0","article-title":"Predictors of vascular complications among type 2 diabetes mellitus patients at University of Gondar referral Hospital: a retrospective follow-up study","volume":"18","author":"Wolde","year":"2018","journal-title":"BMC Endocr Disord"},{"key":"2021122408400974000_9.2.e002466.33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133494"},{"key":"2021122408400974000_9.2.e002466.34","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1167\/iovs.15-16504","article-title":"High-Fat diet induces Toll-like receptor 4-dependent macrophage\/microglial cell activation and retinal impairment","volume":"56","author":"Lee","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122408400974000_9.2.e002466.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015473"},{"key":"2021122408400974000_9.2.e002466.36","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0912"},{"key":"2021122408400974000_9.2.e002466.37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.oret.2017.05.010","article-title":"Diabetic retinopathy in patients with dyslipidemia: development and progression","volume":"2","author":"Jeng","year":"2018","journal-title":"Ophthalmol Retina"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2021-002466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T16:40:37Z","timestamp":1640364037000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2021-002466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,24]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/bmjdrc-2021-002466"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2021-002466","relation":{},"ISSN":["2052-4897"],"issn-type":[{"type":"electronic","value":"2052-4897"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}